title: Higher serum 25-hydroxy vitamin D3 levels at presentation are associated with improved survival from melanoma, but there is no evidence that later prevailing levels are protective.
authors.forename: Peter E
authors.initials: PE
authors.lastname: Hutchinson
authors.forename: Joy E
authors.initials: JE
authors.lastname: Osborne
authors.forename: James H
authors.initials: JH
authors.lastname: Pringle
mesh_terms: D015415:Biomarkers / Q000097:blood; D002762:Cholecalciferol / Q000009:adverse effects / Q000097:blood*; D019587:Dietary Supplements / Q000009:adverse effects; D019317:Evidence-Based Medicine; D006801:Humans; D008545:Melanoma / Q000097:blood* / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000097:blood* / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome; D015854:Up-Regulation
chemical_list: D015415:Biomarkers; D002762:Cholecalciferol